期刊文献+

冠心一号方对冠心病患者的治疗作用及对同型半胱氨酸的影响 被引量:4

Therapeutic Effect of Guanxin Prescription No.1 for Coronary Heart Disease and Its Influence on Homocysteine
下载PDF
导出
摘要 【目的】观察具有益气养阴、活血祛瘀作用的冠心一号方对冠心病患者的治疗作用及对同型半胱氨酸(Hcy)的影响。【方法】将60例冠心病患者随机分为治疗组和对照组各30例。两组均给予常规西药基础治疗,治疗组在基础治疗上加服冠心一号方(由党参、麦冬、五味子、玉竹、川芎、知母、丹参、三七、郁金等组成)。两组均以4周为1个疗程。主要观察治疗后患者临床症状总疗效及心绞痛、心电图疗效,并观察血脂、血清Hcy及颈动脉内膜—中层厚度(IMT)等相关指标改善情况。【结果】治疗组治疗后临床症状总疗效及心绞痛、心电图疗效均优于对照组(P<0.05或P<0.01)。治疗组治疗后血中总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)含量均有下降(P<0.05),而对照组的下降作用不明显(P>0.05)。治疗后治疗组Hcy水平较治疗前显著下降(P<0.05),对照组Hcy水平较治疗前也有所下降,但差异无显著性意义(P>0.05);两组治疗后比较,治疗组Hcy水平下降幅度优于对照组(P<0.05)。【结论】冠心一号方治疗冠心病的疗效优于对照组,而且具有降低冠心病患者同型半胱氨酸的作用。 Objective To observe the therapeutic effect of Guanxin Prescription No. 1 ( GP1 ) for coronary heart disease (CHD) and its influence on homocysteine (Hcy). Methods Sixty CHD patients were equally randomized into two groups. Both of the two groups received routine western medicine, and the treatment group additionally received GP1 (mainly composed of Radix Codonopsis, Radix Ophiopogonis, Fructus Schisandrae Chinensis, Rhizoma Polygonati Odorati, Rhizoma Chuanxiong, Rhizoma Anemarrhenae, Radix Salviae Mihiorrhizae, Radix Notoginseng, Radix Curcumae, etc ). Four weeks constituted one treatment course. The total therapeutic effect and the effect on angina pectoris (AP) and electrocardiogram (ECG) were evaluated after treatment. Meanwhile, the changes of blood lipid levels, serum Hcy and internal-middle thickness (IMT) of carotid artery were observed. Results The total therapeutic effect and the effect on AP and ECG in the treatment group were superior to those in the control group (P 〈0. 05 or P 〈0.01 ). Blood levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and Hcy were decreased in the treatment group after treatment (P 〈 0. 05 compared with those before treatment). No significant difference of the above indexes was found in the control group after treatment (P 〉 0.05 compared with those before treatment). The decrease of serum Hcy level was obvious in the treatment group than that in the control group ( P 〈 0. 05 ). Conclusion Guanxin Prescription No. 1 exerts a certain effect for coronary heart disease, and can decrease the serum level of Hcy.
出处 《广州中医药大学学报》 CAS 2008年第4期285-288,共4页 Journal of Guangzhou University of Traditional Chinese Medicine
基金 广东省中医药管理局科研课题(编号:102112)
关键词 冠心病/中药疗法 冠心一号方/治疗应用 同型半胱氨酸/血液 CORONARY HEART DISEASE/TCD therapy GUANXIN PRESCRIPTION NO. 1 /therapeutic use HOMOCYSTEINE/blood
  • 相关文献

参考文献16

  • 1Ortolani P, Marzocchi A, Marrozzini C, et al. Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina [J]. Ital Heart J, 2004, 5 (3) : 189.
  • 2Dinckal M H, Aksoy N, Aksoy M, et al. Effect of homocysteine lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinemia [ J ]. Acta Cardiol, 2003, 58 (5): 389.
  • 3贝政平.3200个内科疾病诊断标准[S].南京:江苏科学出版社,1998:46-49.
  • 4国家食品药品监督局.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002.
  • 5陈可冀.心脑血管疾病研究[M].上海:上海科技出版社,1998,316?..
  • 6巩书文,刘建立.叶酸、维生素B_(12)治疗高同型半胱氨酸血症35例疗效观察[J].山西临床医药,2002,11(1):32-33. 被引量:10
  • 7Xiaohua Jiang, Fan Yang, Hongmei Tan, et al. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. [ J]. Arterioscler Thromb Vase Biol Dec, 2005, 25 : 2515.
  • 8Austin R C, Lents S R, Werstuck G H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease [J]. Cell Death Differ, 2004, 11 : S55.
  • 9Tofler G H, D'Agostion K B, Jacques P F, et al. Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk [J]. Thromb Haemost, 2002, 88: 799.
  • 10陈健,黎明,舒砚文,廖玉华.叶酸降低高同型半胱氨酸血症大鼠单核细胞趋化蛋白-1的表达[J].中国医学科学院学报,2005,27(4):470-474. 被引量:4

二级参考文献119

共引文献200

同被引文献116

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部